Login
- Title:
GOLD study: An international Phase III study of TKI258/Dovitinib versus Sorafenib in patients with metastatic renal cell cancer (mRCC) as third line therapy
- Document type:
- Meeting Abstract
- Author(s):
- Grunwald, V; Kube, U; Eichelberg, C; Zürn, C; Gschwend, J
- Journal title abbreviation:
- Onkologie
- Year:
- 2012
- Journal volume:
- 35 6
- Pages contribution:
- 202-203
- Language:
- eng
- Print-ISSN:
- 0378-584X
- TUM Institution:
- Urologische Klinik und Poliklinik
BibTeX